Crossmark

Butyrate alleviates adipose mitochondrial dysfunction and inflammation in experimental model of polycystic ovarian syndrome by modulating SIRT1-dependent mechanism

Crossref DOI link: https://doi.org/10.1186/s41110-024-00273-8

Published Online: 2024-06-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Olaniyi, Kehinde S. https://orcid.org/0000-0002-8229-9688
Areloegbe, Stephanie E.
License Information

Text and Data Mining valid from 2024-06-12

Version of Record valid from 2024-06-12
More Information

Article History

Received: 1 February 2024

Accepted: 4 June 2024

First Online: 12 June 2024

Declarations

:

: This research was carried out in adherence to guidelines from the National Institutes of Health Guide for the Care and Maintenance of Laboratory Animals, and the protocol was approved by the Ethical Review Board of Afe Babalola University and the approval number was with the approval number ABUADERC/10B/2022, Nigeria. Consent to participate is not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below